Table 1.

Fluorescence and histopathological features of metastatic brain tumors and adjacent brain in 5-aminorevulinic acid (5-ALA) fluorescence-guided surgery

Case no.	Age sex	Origin of tumor	Histology	Fluorescence of tumor	Fluorescence of adjacent brain tissue	Brain invasion depth (mm)	Preoperative radiation treatment (month)	Preoperative chemotherapy
1	54 F	Breast	Ad	No	Vague	No	−	+
2	70 M	Colon	Ad	No	Vague	Positive (1.7)	−	−
3	63 F	Lung	Ad	Heterogeneous	Vague	Positive (1.2)	−	−
4	56 F	Breast	Ad	No	Vague	Positive (0.7)	−	+
5	76 M	Rectum	Ad	Heterogeneous	Vague	Positive (1.8)	−	+
6	38 M	Unknown	Ad	No	Vague	Positive (2.9)	−	+
7	76 M	Bladder	Sq	No	Vague	No	−	−
8	61 M	Lung	Ad	Heterogeneous	Vague	Positive (3.4)	−	+
9	40 F	Breast	Ad	No	Vague	Positive (0.3)	−	+
10	61 M	Salivary duct	Ad	No	Vague	Positive (0.8)	WBRT (3)	−
11	10 M	Bone	OS	No	No	Positive (0.2)	−	−
12	54 F	Breast	Ad	No	No	No	SRS (27)	+
13	46 M	Lung	Ad	Heterogeneous	Vague	Positive (1.6)	SRS (8)	+
14	67 M	Colon	Ad	No	Vague	Positive (2.0)	SRS (3)	−
15	38 M	Unknown	Ad	No	Vague	Positive (0.3)	−	−
16	49 M	Rectal	Ad	Heterogeneous	Vague	No	−	+

F female, M male, Ad adenocarcinoma, Sq squamous cell carcinoma, OS osteosarcoma, WBRT whole-brain radiation therapy, SRS stereotactic radiosurgery